Effect of anionic polymers on drug loading and release from clindamycin phosphate solid lipid nanoparticles

Tropical Journal of Pharmaceutical Research

Volumn 12, Issue 4, 2013, Pages 477-482

  Abbaspour, Mohammadreza ^a   Makhmalzadeh, Behzad Sharif ^a,b   Arastoo, Zahra ^a   Jahangiri, Alireza ^a,b   Shiralipour, Roohollah ^b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Anionic polymers; Clindamycin; Dextran sulfate; Drug loading; Drug release; Sodium alginate; Solid lipid nanoparticles

Indexed keywords

ALGINIC ACID; CLINDAMYCIN PHOSPHATE; DEXTRAN SULFATE; POLOXAMER; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; STEARIC ACID;

ARTICLE; BRANCHING DENSITY; CHEMICAL PROCEDURES; COLD HOMOGENIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; DRUG LOADING; DRUG RELEASE; DRUG STRUCTURE; EMULSION; FACTORIAL DESIGN; HYDROPHILICITY; IN VITRO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PHARMACEUTICS; PHYSICAL PARAMETERS; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE;

EID: 84882990435     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v12i4.5     Document Type: Article

References (16)

1. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of art. Eur. J. Pharm. Biopharm. 2000; 50: 161-177.
2. Muller RH, Ruge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery. In: Submicron emulsions in drug targeting and delivery. Harwood Academic Publishers, Amsterdam 1998: 219-234.
3. Gulati M, Grover M, Singh M. Lipophilic drug derivatives in liposomes. Int. J. Pharm. 1998; 165: 129-168.
4. Muller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur. J. Pharm. Biopharm. 2004; 58: 343-356.
5. Demiral M, Yazan Y, Muller RH, Kilic F, Bozan B. Formulation and in vitro-in vivo evaluation of piribedil solid lipid nanoparticles. J. Microncapsul. 2001; 18: 359-371.
6. Coppert TM, Muller RH. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int. J. Pharm. 2005; 302: 172-186.
7. Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Del. Rev. 2004; 56: 1257-1272.
8. Mehnert W, Mader K. Solid lipid nanoparticles, production, characterization and applications. Adv. Drug Del. Rev. 2001; 47: 165-197.
9. Sharif Makhmalzadeh B, Barati N, Hassani MH, Rahim F. Development of solid lipid nanoparticles as eschar delivery system for Nitrofurazone using taguchi design Approach. Int. J. Res. Pharm. Sci. 2010; 4: 466-472.
10. Wong HL, Bendayan R, Rauth AM, Wu XY. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J. Pharm. Sci. 2004; 93: 1993-2008.
11. Ricketts CR. Dextran sulphate-a synthetic analogue of heparin. Biochem. J. 1952; 51: 129-133.
12. Mahner C, Lechner MD, Nordmeier E. Synthesis and characterisation of dextran and pullulan sulphate. Carbohydr. Res. 2001; 331: 203-208.
13. Li Y, Wong HL, Shuhendler AJ, Rauth AM, Wu XY. Molecular interactions, internal structure and drug release kinetics of rationally developed polymerlipid hybrid nanoparticles. J. Control. Release 2008; 128: 60-70.
14. Garcia-Fuentes, Torres D, Alonso MJ. New surfacemodified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int. J. Pharm. 2005; 296: 122-132.
15. Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int. J. Pharm. 2004; 273: 29-35.
16. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Del. Rev. 2007; 59: 478-490.